The A$3.4B Healthcare Deal Built on CT Scans and AI
Synopsis
I-MED Radiology’s A$3.4 billion sale highlights rising investor interest in diagnostic imaging businesses as healthcare systems manage growing demand for MRI scans, cancer screening and outpatient diagnostics. The acquisition also reflects broader investment in AI-supported imaging tools and remote radiology services across developed healthcare markets.
Jardine Matheson will acquire I-MED Radiology in a A$3.4 billion deal as imaging demand and healthcare investment continue rising globally.
Key Highlights
- I-MED Radiology will be acquired in a A$3.4 billion transaction including debt.
- The company operates 215 imaging clinics across Australia and New Zealand.
- I-MED performs more than 7 million diagnostic imaging procedures annually.
- The deal includes I-MED’s minority stake in healthcare AI company Harrison.ai.
I-MED Radiology will be bought by Jardine Matheson for a total price of A$3.4 billion ($2.4 billion), including debt, as the demand for diagnostic imaging services continues to grow, driven by the increase in screening rates for healthcare systems and the ageing demographic.
The transaction, which was announced Monday, entails I-MED's minority stake in imaging AI firm Harrison.ai. Permira, a private equity firm that bought the business in 2018, will sell its investment, which will take the company out of the hands of its private investors.
I-MED Radiology have 215 clinics throughout Australia and New Zealand, conducting over 7 million procedures a year. It has MRI, CT, mammography, ultrasound and X-ray services, as well as remote scan reporting operations in New Zealand and the United States.
Imaging Demand Keeps Rising
The I-MED Radiology acquisition adds to the investor attraction of diagnostic imaging companies around the world. Since the outbreak of the COVID-19 pandemic, healthcare systems have experienced steady growth in cancer screening and cardiac imaging, as well as in outpatient diagnostics, such as MRI and CT.
As reported in Reuters and Marketscreener’s transactions, I-MED's annual revenues grew by 11% and its adjusted EBITDA grew by 12% over the past five years to June 2025. The deal puts the value of the business at about 11.5 times the predicted 2026 financial year's adjusted earnings before interest, tax, amortization and depreciation.
But expansion in diagnostic workloads stemming from ageing populations in developed economies has been cited in reports in the healthcare sector by Deloitte and OECD. The demand for imaging in countries such as Japan, Canada, Germany and South Korea has been increasing due to chronic disease management and preventive screening programs.
Healthcare Deals Move to Steady Assets
The I-MED Radiology deal is part of a broader trend in the healthcare infrastructure and outpatient service providers sector. Hospital systems are increasingly focusing on imaging networks, pathology companies and specialist clinics for investment amid capacity challenges and staffing shortages.
The acquisition will be financed by current cash holdings and through debt, said Jardine Matheson. The company anticipates that the transaction will close towards the end of 2026 once regulatory approvals are obtained.
AI and Remote Reporting in Focus
The purchase also highlights the rise in the adoption of AI-backed imaging technologies and teleradiology. The investment in Harrison.ai is part of a trend of I-MED's portfolio in health systems software that assists radiologists in reviewing scans more quickly and handling rising volume.
Analysts have observed that the growth in remote reporting services has been strong since COVID-19, especially in the regional healthcare networks where specialists are lacking.
FAQs
Q1. Why is I-MED Radiology being acquired in a multi-billion-dollar deal?
I-MED operates one of the region’s largest imaging clinic networks, with growing demand for MRI, CT, and cancer screening services driving investor interest.
Q2. How big is I-MED Radiology’s healthcare network?
I-MED runs 215 clinics across Australia and New Zealand and performs more than 7 million imaging procedures every year.
Q3. Why are investors focusing on diagnostic imaging companies?
Healthcare investors are targeting imaging businesses due to ageing populations, rising chronic disease cases, and increasing demand for outpatient diagnostic services.
Follow Inspirepreneur Magazine for daily global business news.
Pooja Malik is a business journalist with over six years of experience covering startups, entrepreneurship, and emerging trends. She has previously worked with leading media platforms such as YourStory Media and BW BusinessWorld, where she reported on business, policy, and market developments. Currently, she serves as Editor at The Inspirepreneur Magazine, where she writes and edits stories across business, lifestyle, and travel, with a focus on clarity, accuracy, and reader relevance.
